Investigating the recrystallization behavior of amorphous paracetamol by variable temperature Raman studies and surface raman mapping

Molecular Pharmaceutics

Volumn 9, Issue 6, 2012, Pages 1544-1558

  Nanubolu, Jagadeesh Babu ^a   Burley, Jonathan C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

amorphous; bulk; covered; crystallization; disorder; glass transition; glassy; MCR; PCA; peak position; peak width; phase transition; polymorph; Raman mapping; Raman spectroscopy; supercooled liquid; surface; uncovered; variable temperature

Indexed keywords

PARACETAMOL;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; DRUG STABILITY; GEOMETRY; IMAGING SYSTEM; PRIORITY JOURNAL; RAMAN SPECTROMETRY; RAMAN SURFACE MAPPING; THERMOSTABILITY;

ACETAMINOPHEN; CRYSTALLIZATION; PRINCIPAL COMPONENT ANALYSIS; SPECTRUM ANALYSIS, RAMAN; TEMPERATURE;

EID: 84862025125     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300035g     Document Type: Article

References (87)

1. Hancock, B. C.; Parks, M. What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 2000, 17, 397-404. (Pubitemid 30395293)
2. (a) Yu, L. Amorphous pharmaceutical solids: preparation, characterization, and stabilization. Adv. Drug Delivery Rev. 2001, 48, 27-42.
3. (b) Bhattacharya, S.; Suryanarayanan, R. Local mobility in amorphous pharmaceuticals-characterization and implications on stability. J. Pharm. Sci. 2009, 98, 2935-2953.
4. (a) Petit, S.; Coquerel, G. The Amorphous State. In Polymorphism in pharmaceutical industry; Hilfiker, R., Ed.; Wiley-VCH Verlag GmbH & Co. KGaA: 2006, pp 259-287.
5. (b) Hancock, B. C.; Shalaev, E. Y.; Shamblin, S. L. Polyamorphism: a pharmaceutical science perspective. J. Pharm. Pharmacol. 2002, 54, 1151-1152.
6. (c) Craig, D. Q. M.; Kett, V. L.; Murphy, J. R.; Price, D. M. The Measurement of Small Quantities of Amorphous Material-Should We Be Considering the Rigid Amorphous Fraction? Pharm. Res. 2001, 18, 1081-1082. (Pubitemid 32900390)
7. (d) Angell, C. A.; Sare, E. J. Glass-Forming Composition regions and glass transition temperatures for aqueous electrolyte solutions. J. Chem. Phys. 1970, 52, 1058-1068.
8. (a) Savolainen, M.; Heinz, A.; Strachan, C.; Gordon, K. C.; Yliruusi, J.; Rades, T.; Sandler, N. Screening for differences in the amorphous state of indomethacin using multivariate visualization. Eur. J. Pharm. Sci. 2007, 30, 113-123.
9. (b) Patterson, J. E.; James, M. B.; Forster, A. H.; Lancaster, R. W.; Butler, J. M.; Rades, T. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds. J. Pharm. Sci. 2005, 94, 1998-2012. (Pubitemid 41551483)
10. (a) Surana, R.; Pyne, A.; Suryanarayan, R. Effect of Preparation Method on Physical Properties of Amorphous Trehalose. Pharm. Res. 2004, 21, 1167-1176.
11. (b) Yonemochi, E.; Ueno, Y.; Ohmae, T.; Oguchi, T.; Nakajima, S.; Yamamoto, K. Evaluation of Amorphous Ursodeoxycholic Acid by Thermal Methods. Pharm. Res. 1997, 14, 798-803. (Pubitemid 27281677)
12. (c) Yonemochi, E.; Inoue, Y.; Buckton, G.; Moffat, A.; Oguchi, T.; Yamamoto, K. Differences in Crystallization Behavior Between Quenched and Ground Amorphous Ursodeoxycholic Acid. Pharm. Res. 1999, 16, 835-840. (Pubitemid 29284193)
13. (d) Trasi, N. S.; Boerrigter, S. X. M.; Byrn, S. R. Investigation of the Milling-Induced Thermal Behavior of Crystalline and Amorphous Griseofulvin. Pharm. Res. 2010, 27, 1377-1389.
14. (e) Graeser, K. A.; Strachan, C. J.; Patterson, J. E.; Gordon, K. C.; Rades, T. Physicochemical Properties and Stability of Two Differently Prepared Amorphous Forms of Simvastatin. Cryst. Growth Des. 2008, 8, 128-135.
15. (a) Sheth, A. R.; Bates, S.; Muller, F. X.; Grant, D. J. W. Local Structure in Amorphous Phases of Piroxicam from Powder X-ray Diffractometry. Cryst. Growth Des. 2005, 5, 571-578.
16. (b) Sheth, A. R.; Bates, S.; Muller, F. X.; Grant, D. J. W. Polymorphism in Piroxicam. Cryst. Growth Des. 2004, 4, 1091-1098. (Pubitemid 39531985)
17. Wanapun, D.; Kestur, U. S.; Kissick, D. J.; Simpson, G. J.; Taylor, L. S. Selective Detection and Quantitation of Organic Molecule Crystallization by Second Harmonic Generation Microscopy. Anal. Chem. 2010, 82, 5425-5432.
18. (a) Willart, J. F.; Descamps, M. Solid State Amorphization of Pharmaceuticals. Mol. Pharmaceutics 2008, 5, 905-920.
19. (b) Champion, D.; Le Meste, M.; Simatos, D. Towards an improved understanding of glass transition and relaxations in foods: molecular mobility in the glass transition range. Trends Food Sci. Technol. 2000, 11, 41-55.
20. (c) Angell, C. A. Formation of Glasses from Liquids and Biopolymers. Science 1995, 267, 1924-1935.
21. (a) http://www.metrotec.es/metrotec/WWW-DOC/PETech- 09.pdf.
22. (b) Clas, S.; Dalton, C. R.; Hancock, B. C. Differential scanning calorimetry: applications in drug development. Pharm. Sci. Technol. Today 1999, 2, 311-320. (Pubitemid 29378535)
23. (a) Coleman, N. J.; Craig, D. Q. M. Modulated temperature differential scanning calorimetry: A novel approach to pharmaceutical thermal analysis. Int. J. Pharm. 1996, 135, 13-29.
24. (b) Verdonck, E.; Schaap, K.; Thomas, L. C. A discussion of the principles and applications of Modulated Temperature DSC (MTDSC). Int. J. Pharm. 1999, 192, 3-20.
25. (c) Thomas, L. C. MDSC Applications. Solutions to Materials Characterization Problems. Netsu Sokutei 1995, 22, 85-87.
26. (d) Jens, R. The glass transition temperature Tg of polymers - Comparison of the values from differential thermal analysis (DTA, DSC) and dynamic mechanical measurements (torsion pendulum). Polym. Test. 2001, 20, 199-204.
27. Tabellout, M.; Baillif, P.-Y.; Randrianantoandro, H.; Litzinger, F.; Emery, J. R.; Nicolai, T.; Durand, D. Glass-transition dynamics of a polyurethane gel using ultrasonic spectroscopy, dynamic light scattering, and dynamical mechanical thermal analysis. Phys. Rev. B: Condens. Matter Mater. Phys. 1995, 51, 12295-12302.
28. (a) Gupta, P.; Bansal, A. K. Devitrification of amorphous celecoxib. AAPS PharmSciTech 2005, 6, E223-E230.
29. (b) Kets, E. P. W.; IJpelaar, P. J.; Hoekstra, F. A.; Vromans, H. Citrate increases glass transition temperature of vitrified sucrose preparations. Cryobiology 2004, 48, 46-54.
30. (a) Pschorn, U.; Roessler, E.; Sillescu, H.; Kaufmann, S.; Schaefer, D.; Spiess, H. W. Local and cooperative motions at the glass transition of polystyrene: information from one- and two-dimensional NMR as compared with other techniques. Macromolecules 1991, 24, 398-402.
31. (b) Kuebler, S. C.; Schaefer, D. J.; Boeffel, C.; Pawelzik, U.; Spiess, H. W. 2D Exchange NMR Investigation of the α-Relaxation in Poly(ethyl methacrylate) as Compared to Poly(methyl methacrylate). Macromolecules 1997, 30, 6597-6609. (Pubitemid 127564851)
32. (c) Ruan, R.; Long, Z.; Chen, P.; Huang, V.; Almaer, S.; Taub, I. Pulse NMR Study of Glass Transition in Maltodextrin. J. Food Sci. 1999, 64, 6-9. (Pubitemid 29126038)
33. (d) Kalichevsky, M. T.; Jaroszkiewicz, E. M.; Ablett, S.; Blanshard, J. M. V.; Lillford, P. J. The glass transition of amylopectin measured by DSC, DMTA and NMR. Carbohydr. Polym. 1992, 18, 77-88.
34. (a) Park, I.; Saruta, K.; Kojima, S. Dielectric Relaxation and Calorimetric Measurements of Glass Transition in the Glass-Forming Dyhydroxyl Alcohols. J. Phys. Soc. Jpn. 1998, 67, 4131-4138.
35. (b) Dionísio, M.; Viciosa, M. T.; Wang, Y.; Mano, J. F. Glass Transition Dynamics of Poly(L-lactic acid) during Isothermal Crystallisation Monitored by Real-Time Dielectric Relaxation Spectroscopy Measurements. Macromol. Rapid Commun. 2005, 26, 1423-1427. (Pubitemid 41321671)
36. (c) Puertas, R.; Rute, M. A.; Salud, J.; López, D. O.; Diez, S.; van Miltenburg, J. K.; Pardo, L. C.; Tamarit, J. L.; Barrio, M.; Pérez-Jubindo, M. A.; de la Fuente, M. R. Thermodynamic, crystallographic, and dielectric study of the nature of glass transitions in cyclo-octanol. Phys. Rev. B: Condens. Matter Mater. Phys. 2004, 69, 224202.
37. (d) Jansson, H.; Swenson, J. The protein glass transition as measured by dielectric spectroscopy and differential scanning calorimetry. Biochem. Biophys. Acta, Proteins Proteomics 2010, 1804, 20-26.
38. (a) Marsac, P. J.; Konno, H.; Taylor, L. S. A Comparison of the Physical Stability of Amorphous Felodipine and Nifedipine Systems. Pharm. Res. 2006, 23, 2306-2316.
39. (b) Chawla, G.; Bansal, A. K. Molecular Mobility and Physical Stability of Amorphous Irbesartan. Sci. Pharm. 2009, 77, 695-709.
40. (c) Kawai, K.; Hagiwara, T.; Takai, R.; Suzuki, T. Comparative Investigation by Two Analytical Approaches of Enthalpy Relaxation for Glassy Glucose, Sucrose, Maltose, and Trehalose. Pharm. Res. 2005, 22, 490-495. (Pubitemid 40575657)
41. Mahlin, D.; Berggren, J.; Alderborn, G.; Engström, S. Moisture- Induced Surface Crystallization of Spray-Dried Amorphous Lactose Particles Studied by Atomic Force Microscopy. J. Pharm. Sci. 2004, 93, 29-37.
42. (a) Naumov, D. Y.; Vasilchenko, M. A.; Howard, J. A. K. The Monoclinic Form of Acetaminophen at 150K. Acta Crystallogr., Sect. C: Cryst. Struct. Commun. 1998, 54, 653-655.
43. (b) Nichols, C.; Frampton, C. S. Physicochemical Characterization of the Orthorhombic Polymorph of Paracetamol Crystallized from Solution. J. Pharm. Sci. 1998, 87, 684-93. (Pubitemid 28268566)
44. (c) Perrin, M. A.; Neumann, M. A.; Elmaleh, H.; Zaske, L. Crystal structure determination of the elusive paracetamol Form III. Chem. Commun. 2009, 3181-3183.
45. (d) Di Martino, P.; Guyot-Hermann, A.; Conflant, P.; Drache, M.; Guyot, J. A new pure paracetamol for direct compression: The orthorhombic form. Int. J. Pharm. 1996, 128, 1-8. (Pubitemid 26092142)
46. (a) Di Martino, P.; Palmieri, G. F.; Martelli, S. Molecular Mobility of the Paracetamol Amorphous Form. Chem. Pharm. Bull. 2000, 48, 1105-1108.
47. (b) Gunawan, L.; Johari, G. P.; Shanker, R. M. Structural Relaxation of Acetaminophen Glass. Pharm. Res. 2006, 23, 967-979. (Pubitemid 43781405)
48. (a) Kauffman, J. F.; Batykefer, L. M.; Tuschel, D. D. Raman detected differential scanning calorimetry of polymorphic transformations in acetaminophen. J. Pharm. Biomed. Anal. 2008, 48, 1310-1315.
49. (b) Gaisford, S.; Buanz, A. B. M.; Jethwa, N. Characterisation of paracetamol form III with rapid-heating DSC. J. Pharm. Biomed. Anal. 2010, 53, 366-370.
50. (c) Ledru, J.; Imrie, C. T.; Pulham, C. R.; Céolin, R.; Hutchinson, J. M. High pressure differential scanning calorimetry investigations on the pressure dependence of the melting of paracetamol Polymorphs I and II. J. Pharm. Sci. 2007, 96, 2784-2794. (Pubitemid 47597827)
51. (d) Picciochi, R.; Diogo, H. P.; Minas da Piedade, M. E. Thermochemistry of paracetamol. J. Therm. Anal. Calorim. 2010, 100, 391-401.
52. (e) Al-Zoubi, N.; Koundourellis, J. E.; Malamataris, S. FT-IR and Raman spectroscopic methods for identification and quantitation of orthorhombic and monoclinic paracetamol in powder mixes. J. Pharm. Biomed. Anal. 2002, 29, 459-467. (Pubitemid 34607806)
53. (f) Moynihan, H. A.; O'Hare, I. P. Spectroscopic characterisation of the monoclinic and orthorhombic forms of paracetamol. Int. J. Pharm. 2002, 247, 179-185. (Pubitemid 35341149)
54. (a) Perlovich, G. L.; Volkova, T. V.; Bauer-Brandl, A. Polymorphism of paracetamol. Relative stability of the monoclinic and orthorhombic phase revisited by sublimation and solution chemistry. J. Therm. Anal. Calorim. 2007, 89, 767-774.
55. (b) Espeau, P.; Céolin, R.; Tamarit, J.; Perrin, M.; Gauchi, J.; Leveiller, F. Polymorphism of Paracetamol: Relative Stabilities of the Monoclinic and Orthorhombic Phases Inferred from Topological Pressure-Temperature and Temperature-Volume Phase Diagrams. J. Pharm. Sci. 2005, 94, 524-539. (Pubitemid 40480966)
56. Burley, J. C.; Duer, M. J.; Stein, R. S.; Vrcelj, R. M. Enforcing Ostwald's rule of stages: Isolation of paracetamol forms III and II. Eur. J. Pharm. Sci. 2007, 31, 271-276. (Pubitemid 47068938)
57. Di Martino, P.; Conflant, P.; Drache, M.; Huvenne, J. -P.; Guyot-Hermann, A. -M. Preparation and Physical Characterisation of Forms II and III of Paracetamol. J. Therm. Anal. 1997, 48, 447-458. (Pubitemid 127782084)
58. Qi, S.; Avalle, P.; Saklatvala, R.; Craig, D. Q. M. An investigation into the effects of thermal history on the crystallisation behaviour of amorphous paracetamol. Eur. J. Pharm. Biopharm. 2008, 69, 364-371. (Pubitemid 351471777)
59. Cambridge Structural Database (version 5.32), November 2011 release, ConQuest 1.14, February 2012 update, The Cambridge Crystallographic Data Centre, Cambridge (U.K.), to be found under www.ccdc.cam.ac.uk.
60. Pharmaceutical Applications of Raman Spectroscopy; Šǎ; ić, S., Ed.; John Wiley & Sons, Inc.: Hoboken, NJ, 2008.
61. Johansson, J.; Pettersson, S.; Taylor, L. S. Infrared imaging of laser-induced heating during Raman spectroscopy of pharmaceutical solids. J. Pharm. Biomed. Anal. 2002, 30, 1223-1231. (Pubitemid 35284334)
62. (a) http://plasma-gate.weizmann.ac.il/Grace/.
63. (b) http:// ctioga2.rubyforge.org/.
64. http://www.r-project.org/. http://watson.nci.nih.gov/bioc- mirror/packages/2.3/bioc/html/pcaMethods.html. http://cran.rproject.org/web/ packages/ALS/index.html.
65. StatSoft, Inc. Electronic Statistics Textbook; StatSoft: Tulsa, OK, 2010. Web: http://www.statsoft.com/textbook/.
66. (a) http://www.gaussian.com/.
67. (b) http://gabedit. sourceforge.net/.
68. (a) Andersson, M. P.; Uvdal, P. New Scale Factors for Harmonic Vibrational Frequencies Using the B3LYP Density Functional Method with Triple-ζ Basis Set 6-311+G(d,p). J. Phys. Chem. A 2005, 109, 2937-2941.
69. (b) Banisaukas, B.; Szczepanski, J.; Eyler, J.; Vala, M.; Hirata, S.; Head-Gordon, M.; Oomens, J.; Meijer, G.; von Helden, G. Vibrational and Electronic Spectroscopy of Acenaphthylene and Its Cation. J. Phys. Chem. A 2003, 107, 782-993.
70. (a) Burgina, E. B.; Baltakhinov, V. P.; Boldyreva, E. V.; Shakhtschneider, T. P. IR Spectra of Paracetamol and Phenacitin.1.- Theoretical and Experimental studies. J. Struct. Chem. 2004, 45, 64-73.
71. (b) Binev, I. G.; Vassileva-Boyadjieva, P.; Binev, Y. I. Experimental and ab initio MO studies on the IR spectra and structure of 4- hydroxyacetanilide (paracetamol), its oxyanion and dianion. J. Mol. Struct. 1998, 447, 235-246. (Pubitemid 29159083)
72. (a) Al-Dulaimi, S.; Aina, A.; Burley, J. Rapid polymorph screening on milligram quantities of pharmaceutical material using phonon-mode Raman spectroscopy. CrystEngComm 2010, 12, 1038-1040.
73. (b) Alkhalil, A.; Nanubolu, J. B.; Burley, J. C. Analysis of phase transitions in molecular solids: quantitative assessment of phononmode vs intra-molecular spectral data. RSC Adv. 2012, 2, 209-216.
74. (c) Brillante, A.; Bilotti, I.; Valle, R. G. D.; Venuti, E.; Girlando, A. Probing polymorphs of organic semiconductors by lattice phonon Raman microscopy. CrystEngComm 2008, 10, 937-946.
75. (d) Ayala, A. P. Polymorphism in drugs investigated by low wavenumber Raman scattering. Vib. Spectrosc. 2007, 45, 112-116. (Pubitemid 350180363)
76. (a) Ganguly, S.; Parthasarathy, R.; Rao, K. J.; Rao, C. N. R. Analysis of Raman bandwidths and bandshapes of glasses through their glass-transition temperatures. J. Chem. Soc., Faraday Trans. 2 1984, 80, 1395-1404.
77. (b) Resmi, M. R.; George, L.; Singh, S.; Pradeep, T.; Sankar, K. U. Infrared spectroscopic study of the structural transitions of C60Br24. J. Mol. Struct. 1997, 435, 11-15.
78. (c) Zhang, M.; Salje, E. K H.; Putnis, A. Phase transitions in LiKSO4 between 1.5 and 850 K: an infrared spectroscopic study. J. Phys., Condens. Matter 1998, 10, 11811-11827. (Pubitemid 128571962)
79. (d) Shim, S.; Duffy, T. S.; Jeanloz, R.; Yoo, C.; Iota, V. Raman spectroscopy and x-ray diffraction of phase transitions in Cr2O3 to 61 GPa. Phys. Rev. B: Condens. Matter Mater. Phys. 2004, 69, 144107.
80. (a) Wu, T.; Yu, L. Surface Crystallization Indomethacin Below Tg. Pharm. Res. 2006, 23, 2350-2355.
81. (b) Zhu, L.; Wong, L.; Yu, L. Surface-Enhanced Crystallization of Amorphous Nifedipine. Mol. Pharmaceutics 2008, 5, 921-926.
82. (c) Zhu, L.; Jona, J.; Nagapudi, K.; Wu, T. Fast Surface Crystallization of Amorphous Griseofulvin below Tg. Pharm. Res. 2010, 27, 1558-1567.
83. (d) Wu, T.; Sun, Y.; Li, N.; de Villiers, M. M.; Yu, L. Inhibiting Surface Crystallization of Amorphous Indomethacin by Nanocoating. Langmuir 2007, 23, 5148-5153. (Pubitemid 46732007)
84. (a) Gordon, K. C.; McGoverin, C. M. Raman mapping of pharmaceuticals. Int. J. Pharm. 2011, 417, 151-162.
85. (b) Šašić, S.; Clark, D. A.; Mitchell, J. C.; Snowden, M. J. Raman line mapping as a fast method for analyzing pharmaceutical bead formulations. Analyst 2005, 130, 1530-1536. (Pubitemid 41617750)
86. (c) Šašić, S. Raman Mapping of Low-Content API Pharmaceutical Formulations. I. Mapping of Alprazolam in Alprazolam/Xanax Tablets. Pharm. Res. 2007, 24, 58-65. (Pubitemid 44902570)
87. (d) Alkhalil, A.; Nanubolu, J. B.; Roberts, C. J.; Aylott, J. W.; Burley, J. C. Confocal Raman Microscope Mapping of a Kofler Melt. Cryst. Growth Des. 2011, 11, 422-430.